EDNRB
Endothelin receptor type B
Also known as: EDNRB_HUMAN, ETB, HSCR, HSCR2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P24530
- Gene
- EDNRB
- Ensembl
- ENSG00000136160
- Chromosome
- 13
- Canonical length
- 442 aa
- Protein class
- Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a G protein-coupled receptor which activates a phosphatidylinositol-calcium second messenger system. Its ligand, endothelin, consists of a family of three potent vasoactive peptides: ET1, ET2, and ET3. Studies suggest that the multigenic disorder, Hirschsprung disease type 2, is due to mutations in the endothelin receptor type B gene. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016]
Canonical amino-acid sequenceUniProt
442 residues, UniProt reviewed canonical sequence.
>P24530|EDNRB
1 MQPPPSLCGR ALVALVLACG LSRIWGEERG FPPDRATPLL QTAEIMTPPT KTLWPKGSNA
61 SLARSLAPAE VPKGDRTAGS PPRTISPPPC QGPIEIKETF KYINTVVSCL VFVLGIIGNS
121 TLLRIIYKNK CMRNGPNILI ASLALGDLLH IVIDIPINVY KLLAEDWPFG AEMCKLVPFI
181 QKASVGITVL SLCALSIDRY RAVASWSRIK GIGVPKWTAV EIVLIWVVSV VLAVPEAIGF
241 DIITMDYKGS YLRICLLHPV QKTAFMQFYK TAKDWWLFSF YFCLPLAITA FFYTLMTCEM
301 LRKKSGMQIA LNDHLKQRRE VAKTVFCLVL VFALCWLPLH LSRILKLTLY NQNDPNRCEL
361 LSFLLVLDYI GINMASLNSC INPIALYLVS KRFKNCFKSC LCCWCQSFEE KQSLEEKQSC
421 LKFKANDHGY DNFRSSNKYS SSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EDNRB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 120 nTPM
Expression across tissuesHPA
Tissue
- placenta: 120 nTPM
- adipose tissue: 60 nTPM
- basal ganglia: 52 nTPM
- cerebral cortex: 49 nTPM
- lung: 48 nTPM
- liver: 48 nTPM
Single-cell type
- melanocytes: 750 nCPM
- astrocytes: 305 nCPM
- pericytes: 262 nCPM
- lymphatic endothelial cells: 193 nCPM
- bergmann glia: 186 nCPM
- hepatic stellate cells: 174 nCPM
Immune cell
- classical monocyte: 0.4 nTPM
- intermediate monocyte: 0.4 nTPM
- total PBMC: 0.1 nTPM
- basophil: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- spinal cord: 209 nTPM
- white matter: 165 nTPM
- medulla oblongata: 163 nTPM
- midbrain: 144 nTPM
- thalamus: 140 nTPM
- hypothalamus: 111 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about EDNRB.
Disease | AllUniProt
Conditions EDNRB is implicated in, by any mechanism.
- Waardenburg syndrome 4A (WS4A) MIM:277580
- Hirschsprung disease 2 (HSCR2) MIM:600155
- ABCD syndrome (ABCDS) MIM:600501
Disease | GeneticClinVar
40 pathogenic / likely-pathogenic of 382 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Waardenburg syndrome type 4A
- EDNRB-related disorder
- Monogenic hearing loss
- Rare genetic deafness
- ABCD syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.59
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.18
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aldosterone metabolic process
- calcium ion transmembrane transport
- calcium-mediated signaling
- canonical Wnt signaling pathway
- cell surface receptor signaling pathway
- cellular response to lipopolysaccharide
- cGMP-mediated signaling
- chordate pharynx development
- developmental pigmentation
- endothelin receptor signaling pathway
- enteric nervous system development
- epithelial fluid transport
- establishment of endothelial barrier
- gene expression
- heparin proteoglycan metabolic process
- macrophage chemotaxis
- melanocyte differentiation
- negative regulation of adenylate cyclase activity
- negative regulation of apoptotic process
- negative regulation of neuron maturation
- negative regulation of protein metabolic process
- negative regulation of transcription by RNA polymerase II
- nervous system development
- neural crest cell migration
- neuroblast migration
- peripheral nervous system development
- phospholipase C-activating G protein-coupled receptor signaling pathway
- podocyte differentiation
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of cell population proliferation
- positive regulation of cytosolic calcium ion concentration
- positive regulation of penile erection
- positive regulation of urine volume
- posterior midgut development
- protein transmembrane transport
- regulation of epithelial cell proliferation
- regulation of fever generation
- regulation of heart rate
- regulation of pH
- renal albumin absorption
- renal sodium excretion
- renal sodium ion absorption
- renin secretion into blood stream
- response to pain
- response to sodium phosphate
- vasoconstriction
- vasodilation
- vein smooth muscle contraction
- enteric smooth muscle cell differentiation
- response to endothelin
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EDNRB as an antibody target. Whether an autoantibody or antibody against EDNRB could matter depends on whether native EDNRB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EDNRB is annotated at the cell surface, where native EDNRB is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label EDNRB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...